Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy.

Simple item page
dc.contributor.affiliationCentre for Infectious Disease Research in Zambia, PO Box 34681, Plot 5977 Benakale Road, Northmead, Lusaka, Zambia. stewart@cidrz.org
dc.contributor.affiliationCIDRZ
dc.contributor.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.contributor.authorReid SE
dc.contributor.authorReid CA
dc.contributor.authorVermund SH
dc.date.accessioned2025-05-23T11:43:05Z
dc.date.issued2004-Nov
dc.description.abstractDeclining drug costs and increases in international donor interest are leading to greater availability of antiretroviral treatment programmes for persons living with the human immunodeficiency virus in parts of sub-Saharan Africa. Ensuring adequate adherence to antiretroviral drug therapy is one of the principal challenges facing successful implementation in Africa, where 70% of the world's infected persons live. Tuberculosis and leprosy are two diseases of global importance whose control programmes can provide important lessons for developing antiretroviral drug adherence strategies. This paper examines various approaches used in tuberculosis and leprosy control which could help enhance adherence to antiretroviral therapy in resource-limited settings.
dc.identifier.doi10.1258/0956462042395195
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/10772
dc.sourceInternational journal of STD & AIDS
dc.titleAntiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy.

Files

Collections

Published